Hypertension and Postoperative Pain: A Prospective Observational Study

Table 2

Comparisons of postoperative outcomes in female patients unadjusted and adjusted for age and weight ().

		Normotensive ()	H/T without M ()	H/T with M ()	value	Adjusted value
POD1	VASM1	4.3 ± 1.9	4.6 ± 1.9	4.6 ± 1.8	0.662	0.909
	VASR1	1.9 ± 1.6	2.4 ± 1.7	2.1 ± 1.8	0.364	0.305
	DOSE1 (mL)	61.0 ± 34.4	68.6 ± 39.7	74.4 ± 44.9^†	0.330	0.021^!
	PONV1	1 (2.5%)	2 (4.6%)	4 (10.5%)
POD2	VASM2	3.3 ± 1.8	3.6 ± 1.3	3.6 ± 1.6	0.604	0.771
	VASR2	1.2 ± 1.5	1.5 ± 1.3	1.3 ± 1.1	0.593	0.588
	DOSE2 (mL)	101.7 ± 49.0	115.5 ± 66.4	125.1 ± 56.7^†	0.206	0.014^!
	PONV2	1 (2.5%)	2 (4.6%)	0 (0%)
POD3	VASM3	2.5 ± 1.6	2.8 ± 1.7	2.7 ± 1.3	0.734	0.750
	VASR3	0.9 ± 0.9	0.9 ± 1.0	0.7 ± 0.9	0.710	0.808
	DOSE3 (mL)	132.4 ± 71.4	144.4 ± 91.1	157.9 ± 71.4^†	0.366	0.032^!
	PONV3	0 (0%)	0 (0%)	1 (2.6%)

Data are presented as mean ± SD or number (%). POD1: postoperative day 1; POD2: postoperative day 2; POD3: postoperative day 3; PONV: postoperative nausea and vomiting; VASM: analogue scales on movement; VASR: analogue scales at rest; DOSE: postoperative morphine consumption (0.4 mg/mL). ^!Adjusted for independent-samples, one-way ANCOVA (age and weight as covariates). ⁺Adjusted when comparing the normotensive and H/T with medication groups.